Ignite Creation Date:
2024-07-17 @ 10:57 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06463509
Status:
COMPLETED
Last Update Posted:
2024-06-17
First Post:
2024-05-15
Brief Title:
Establishment and Standardization of a Platform for In-depth Tumour Profiling TUPRO in Patients With Melanoma
Sponsor:
Reinhard Dummer
Organization:
University of Zurich
Study Overview
Official Title:
Establishment and Standardization of a Platform for In-depth Tumour Profiling TUPRO in Patients With Advanced Melanoma - a Prospective Multicentric HFV Research ProjectCategory A
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TUPRO
Brief Summary:
TUPRO-Melanoma is the first project of the Tumour Profiler TUPRO research collaboration which in the long-term aims to generate data that will help to understand and report the individual tumour biology and the clinical parameters for patients with advanced malignancies using innovative molecular technologies and computational analyses for in-depth molecular profiling TUPRO-Melanoma is an exploratory project that aims to establish a comprehensive platform for in-depth tumour profiling in patients suffering from advanced melanoma Aims of this platform are to establish logistics and algorithms for integrative analyses and discover new molecular biomarker profilespatterns
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None